-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Chronic heart failure (HF) is a complex disease involving multiple pathophysiological mechanisms, including cardiomyocyte apoptosis, inflammation, and altered electrical signals, leading to frequent hospitalizations and deaths in HF patients
Heart failure
Recently, the heart blood vessels authority areas Circ-Heart magazine published a research article on Fail, the researchers first assessed the median follow-up of 2 years in the plasma of patients with HF N- acetylneuraminic acid levels associated with adverse cardiovascular events between the incidence of ’S association
Heart blood vessel cardiovascular events immunity
Among the 1699 patients with heart failure, 464 (27%) died of cardiovascular-related deaths or received heart transplants
In addition, in the heart tissue of HF patients, the expression of neuraminidase is up-regulated and accompanied by desialylation
Thus, the study revealed a significant correlation between the increase in plasma N-acetylneuraminic acid levels and the increased risk of poor clinical prognosis in HF patients
This study revealed a significant correlation between the increase in plasma N-acetylneuraminic acid levels and the increased risk of poor clinical prognosis in HF patients
Original source:
Chenze Li,et al.